BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 34502108)

  • 1. Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art.
    de Castro MJ; Del Toro M; Giugliani R; Couce ML
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for neurologic manifestations of mucopolysaccharidoses.
    Wolf DA; Banerjee S; Hackett PB; Whitley CB; McIvor RS; Low WC
    Expert Opin Drug Deliv; 2015 Feb; 12(2):283-96. PubMed ID: 25510418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.
    Sato Y; Okuyama T
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.
    Pan D
    Curr Pharm Biotechnol; 2011 Jun; 12(6):884-96. PubMed ID: 21235445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update in the Mucopolysaccharidoses.
    McBride KL; Flanigan KM
    Semin Pediatr Neurol; 2021 Apr; 37():100874. PubMed ID: 33892850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration.
    Lau AA; Hemsley KM
    J Mol Med (Berl); 2017 Oct; 95(10):1043-1052. PubMed ID: 28660346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for Mucopolysaccharidoses.
    Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
    Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy for mucopolysaccharidoses; past, present, and future.
    Chen HH; Sawamoto K; Mason RW; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Tomatsu S
    J Hum Genet; 2019 Nov; 64(11):1153-1171. PubMed ID: 31455839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging drugs for the treatment of mucopolysaccharidoses.
    Giugliani R; Federhen A; Vairo F; Vanzella C; Pasqualim G; da Silva LM; Giugliani L; de Boer AP; de Souza CF; Matte U; Baldo G
    Expert Opin Emerg Drugs; 2016; 21(1):9-26. PubMed ID: 26751109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.
    Sawamoto K; Stapleton M; Alméciga-Díaz CJ; Espejo-Mojica AJ; Losada JC; Suarez DA; Tomatsu S
    Drugs; 2019 Jul; 79(10):1103-1134. PubMed ID: 31209777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches.
    Fraldi A; Serafini M; Sorrentino NC; Gentner B; Aiuti A; Bernardo ME
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):130. PubMed ID: 30442177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and potential therapeutic strategies for mucopolysaccharidoses.
    Noh H; Lee JI
    J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene delivery strategies for the treatment of mucopolysaccharidoses.
    Baldo G; Giugliani R; Matte U
    Expert Opin Drug Deliv; 2014 Mar; 11(3):449-59. PubMed ID: 24450877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapies for mucopolysaccharidoses.
    Rossi A; Brunetti-Pierri N
    J Inherit Metab Dis; 2024 Jan; 47(1):135-144. PubMed ID: 37204267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and II clinical trials for the mucopolysaccharidoses.
    Poswar F; Baldo G; Giugliani R
    Expert Opin Investig Drugs; 2017 Dec; 26(12):1331-1340. PubMed ID: 29065735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for mucopolysaccharidosis.
    Ponder KP; Haskins ME
    Expert Opin Biol Ther; 2007 Sep; 7(9):1333-45. PubMed ID: 17727324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucopolysaccharidoses I and II: Brief Review of Therapeutic Options and Supportive/Palliative Therapies.
    Nan H; Park C; Maeng S
    Biomed Res Int; 2020; 2020():2408402. PubMed ID: 33344633
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanotechnology applied to treatment of mucopolysaccharidoses.
    Schuh RS; Baldo G; Teixeira HF
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1709-1718. PubMed ID: 27322551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and applications of gene therapy vectors for mucopolysaccharidosis in Colombia.
    Alméciga-Diaz CJ; Barrera LA
    Gene Ther; 2020 Feb; 27(1-2):104-107. PubMed ID: 31267008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.